Marshall Wace’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.8M | Buy |
955,150
+683,327
| +251% | +$7.7M | 0.01% | 735 |
|
|
2025
Q1 | $2.74M | Sell |
271,823
-2,675,131
| -91% | -$27M | ﹤0.01% | 1246 |
|
|
2024
Q4 | $34.9M | Buy |
2,946,954
+1,505,062
| +104% | +$17.8M | 0.04% | 350 |
|
|
2024
Q3 | $16.6M | Buy |
1,441,892
+727,132
| +102% | +$8.39M | 0.02% | 519 |
|
|
2024
Q2 | $7.56M | Buy |
714,760
+660,660
| +1,221% | +$6.98M | 0.01% | 768 |
|
|
2024
Q1 | $570K | Sell |
54,100
-182,743
| -77% | -$1.93M | ﹤0.01% | 1648 |
|
|
2023
Q4 | $2.66M | Buy |
+236,843
| New | +$2.66M | ﹤0.01% | 928 |
|
|
2023
Q3 | – | Sell |
-1,392,906
| Closed | -$14M | – | 2244 |
|
|
2023
Q2 | $14M | Buy |
1,392,906
+1,093,255
| +365% | +$11M | 0.03% | 531 |
|
|
2023
Q1 | $2.21M | Buy |
299,651
+250,670
| +512% | +$1.85M | ﹤0.01% | 1130 |
|
|
2022
Q4 | $391K | Sell |
48,981
-94,432
| -66% | -$755K | ﹤0.01% | 1893 |
|
|
2022
Q3 | $461K | Buy |
+143,413
| New | +$461K | ﹤0.01% | 2076 |
|